Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR Market Closed
Market Cap: 55.2m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shedir Pharma Srl Unipersonale
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Depreciation & Amortization
-€3.9m
CAGR 3-Years
-22%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Depreciation & Amortization
-€195k
CAGR 3-Years
3%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Pierrel SpA
MIL:PRL
Depreciation & Amortization
-€3.3m
CAGR 3-Years
-44%
CAGR 5-Years
-25%
CAGR 10-Years
2%
Friulchem SpA
MIL:FCM
Depreciation & Amortization
-€860.9k
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.24 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Depreciation & Amortization?
Depreciation & Amortization
-3.9m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Depreciation & Amortization amounts to -3.9m EUR.

What is Shedir Pharma Srl Unipersonale's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-25%

Over the last year, the Depreciation & Amortization growth was -35%. The average annual Depreciation & Amortization growth rates for Shedir Pharma Srl Unipersonale have been -22% over the past three years , -25% over the past five years .

Back to Top